Page last updated: 2024-10-27

flumazenil and Movement Disorders

flumazenil has been researched along with Movement Disorders in 1 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kulisevsky, J1
Avila, A1
Berthier, ML1
Barbanoj, M1

Trials

1 trial available for flumazenil and Movement Disorders

ArticleYear
Double-blind trial of flumazenil in hemiballismus.
    Clinical neuropharmacology, 1994, Volume: 17, Issue:5

    Topics: Aged; Aged, 80 and over; Cross-Over Studies; Double-Blind Method; Female; Flumazenil; GABA Antagonis

1994